Sandra Rojas-caro - Net Worth and Insider Trading

Sandra Rojas-caro Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sandra Rojas-caro owns 2 companies in total, including Spyre Therapeutics Inc (SYRE) , and NeuBase Therapeutics Inc (NBSE) .

Click here to see the complete history of Sandra Rojas-caro’s form 4 insider trades.

Insider Ownership Summary of Sandra Rojas-caro

Ticker	Comapny	Transaction Date	Type of Owner
SYRE	Spyre Therapeutics Inc	2016-05-17	Chief Medical Officer
NBSE	NeuBase Therapeutics Inc	2021-05-24	Chief Medical Officer

Sandra Rojas-caro Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sandra Rojas-caro Ownership Network

Ownership Network List of Sandra Rojas-caro

No Data

Ownership Network Relation of Sandra Rojas-caro

Sandra Rojas-caro Owned Company Details

What does Spyre Therapeutics Inc do?

Who are the key executives at Spyre Therapeutics Inc?

Sandra Rojas-caro is the Chief Medical Officer of Spyre Therapeutics Inc. Other key executives at Spyre Therapeutics Inc include Chief Financial Officer Scott L Burrows , See Remarks Heidy King-jones , and director & 10 percent owner Fairmount Healthcare Co-invest L.p. .

Spyre Therapeutics Inc (SYRE) Insider Trades Summary

Over the past 18 months, Sandra Rojas-caro made no insider transaction in Spyre Therapeutics Inc (SYRE). Other recent insider transactions involving Spyre Therapeutics Inc (SYRE) include a net sale of 18,531 shares made by Scott L Burrows ,

In summary, during the past 3 months, insiders sold 18,531 shares of Spyre Therapeutics Inc (SYRE) in total and bought 0 shares, with a net sale of 18,531 shares. During the past 18 months, 18,531 shares of Spyre Therapeutics Inc (SYRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 18,531 shares.

Spyre Therapeutics Inc (SYRE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Spyre Therapeutics Inc Insider Transactions

No Available Data

Sandra Rojas-caro Mailing Address

Above is the net worth, insider trading, and ownership report for Sandra Rojas-caro. You might contact Sandra Rojas-caro via mailing address: C/o Aeglea Biotherapeutics, Inc., 901 S. Mopac Expressway, Ste. 250, Austin Tx 78746.

Discussions on Sandra Rojas-caro

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.